Navigation Links
China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia
Date:12/1/2009

HARBIN, China, Dec. 1 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company developing and producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that the Company has engaged Guangdong Mediacy Kind Medical Devices Industry Service Company ("MDK") to serve as its exclusive sales agent for the Company's AMI Diagnostic Kit and Human Urinary Albumin Elisa Kit in Southeast Asia.

MDK's management team was impressed by China Sky One Medical's state-of-the-art production facilities and its strict quality control system. MDK, which performed its own market research and financial forecasts, has the utmost confidence in the market prospects of the Company's two new diagnostic kits. The distribution agreement has an initial trial period of three months. A more formal contract will be developed to define the annual sales guidelines.

The AMI Diagnostic Kit is used to diagnose early acute myocardial infarction and the Human Urinary Albumin Elisa Kit is used to diagnose early acute kidney disease. For the first nine months ended September 30, 2009, sales of the AMI Diagnostic Kit reached $7.5 million, accounting for approximately 7.5% of the Company's total revenues. Sales of the Human Urinary Albumin Elisa Kit reached $1.6 million, accounting for approximately 1.6% of the Company's total revenues, during the same period.

"We look forward to a successful collaboration with MDK on the sale of our AMI Diagnostic Kit and our Human Urinary Albumin Elisa Kit, both of which have huge market potential," said Mr. Yan-Qing Liu, Chairman and CEO of China Sky One Medical. "Our international sales team has already built a good market foundation in some Southeast Asian countries. We believe that MDK's mature sales network for medical devices will make this a mutually beneficial agreement."

"As part of our growth strategy, we will continue to expand our sales network in Southeast Asia, which is one of the most attractive overseas markets for China Sky One Medical due to its geographical and cultural proximity to China," Mr. Liu added.

About Guangdong Mediacy Kind Medical Devices Industry Service Company ("MDK")

Headquartered in Zhuhai, China, MDK is a professional medical devices supply chain service provider. MDK is known as a pioneer in its industry and introduced an international medical supply chain management system into China. MDK has built a wide business network in China as well as in other Asian countries, and recorded foreign sales revenues over $100 million over past twelve months. For more information, visit http://www.mdkchina.com .

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio- Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.cski.com.cn .

Safe Harbor Statement

Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding the business collaboration with MDK and other market expansion efforts. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.

    For more information, please contact:

    Company Contact:
     China Sky One Medical, Inc.
     Mr. Stanley Hao, CFO
     Tel:   +86-0451-53994069
     Email: stanleyhao@cski.com.cn

    Investor Relations Contact:
     CCG Investor Relations
     Mr. Crocker Coulson, President
     Tel:   +1-646-213-1915
     Email: crocker.coulson@ccgir.com
     Web:   http://www.ccgirasia.com

SOURCE China Sky One Medical, Inc.


'/>"/>
SOURCE China Sky One Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List
2. WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year
3. China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information
4. Niusule Expands Geographic Footprint in China
5. China Pharma Holdings, Inc. to Present at Brean Murray China Growth Conference
6. China Business Knowledge Launches “China Prospects Forum” -- Dec. 9, 2009, New York City
7. China-Biotics, Inc. Announces Conference Call to Discuss Second Quarter Fiscal 2010 Financial Results
8. China Biologic Schedules Conference Call to Discuss Third Quarter 2009 Financial Results
9. China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates
10. China Sky One Medical, Inc. Announces Conference Call to Discuss Third Quarter 2009 Results
11. China Medicine Announces Conference Call to Discuss Third Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... 2016  Wellcentive today announced it has been ... -based community care organization (CCO) with more ... quality reporting and care management solutions and services. ... of quality managers, analysts and care managers while ... serving FamilyCare members. Oregon ...
(Date:2/11/2016)... 2016   BioInformant announces the February 2016 ... Products, Opportunities, Tools, and Technologies – Market Size, Segments, ... The first and only ... industry, BioInformant has more than a decade of historical ... by stem cell type. This powerful 175 page global ...
(Date:2/10/2016)... , Febr. 10, 2016 /PRNewswire/ - BioAmber Inc. (NYSE: ... to announce that Mitsui & Co. Ltd., its partner ... acid plant, is investing an additional CDN$25 million in ... its stake from 30% to 40%.  Mitsui will also ... acid produced in Sarnia , providing ...
(Date:2/10/2016)... -- ASAE is introducing a hybrid membership model which ... option of joining or renewing through an organizational purchasing ... size, every employee in any size association or AMC ... available member benefits.   John H. Graham, ... will allow organizations of any size and their employees ...
Breaking Biology Technology:
(Date:2/2/2016)... 2, 2016 This BCC Research report ... by reviewing the recent advances in high throughput ... the field forward. Includes forecast through 2019. ... challenges and opportunities that exist in the bioinformatic ... developers, as well as IT and bioinformatics service ...
(Date:2/2/2016)... , Feb. 2, 2016  Based on its ... & Sullivan recognizes US-based Intelligent Retinal Imaging Systems ... Sullivan Award for New Product Innovation. IRIS, a ... North America , is poised to ... growing diabetic retinopathy market. The IRIS technology presents ...
(Date:1/28/2016)... Jan. 28, 2016 Synaptics (NASDAQ: SYNA ), a ... its second quarter ended December 31, 2015. ... of fiscal 2016 increased 2 percent compared to the comparable quarter ... of fiscal 2016 was $35.0 million, or $0.93 per diluted share. ... income for the first quarter of fiscal 2016 grew 9 percent ...
Breaking Biology News(10 mins):